TTENK/calls
The BriefMarketsAll StocksNewsScreenerFeedback

Get the Brief in your inbox

A daily, SEC-grounded read on the market — movers, earnings, and our boldest calls. Free.

TTENK/calls

SEC-grounded equity research — opinionated calls reasoned over real filings.

Research

  • The Brief
  • Markets
  • All Stocks
  • Screener
  • Discover
  • Research
  • The Flip Side
  • Track record

Tools

  • Compare
  • Congress trades
  • Events
  • Filing search
  • Options calculator
  • Leaderboards
  • Insider trades
  • 13F funds
  • Groups
  • Trending
  • News

More

  • Pricing
  • Feedback
  • Newsletter
  • Developers / API
  • Account
DisclosuresTermsPrivacy

Research & education only — not financial advice.TENK is not a registered investment adviser; calls are impersonal, generated from SEC filings and a delayed/third-party price feed, and may be wrong or out of date. The operator and an affiliated trading operation may hold or trade the securities TENK rates — see Disclosures. Do your own research.

EDGAR® is a registered trademark of the U.S. Securities and Exchange Commission. TENK/calls is an independent service and is not affiliated with, endorsed by, or approved by the U.S. Securities and Exchange Commission.

TTENK/calls
The BriefMarketsAll StocksNewsScreenerFeedback

Pulling SEC filings + quote and writing the call…

TTENK/calls
The BriefMarketsAll StocksNewsScreenerFeedback
Home›XPON›Financials
Annual statements · SEC XBRL · FY2021 – FY2025

Expion360 Inc. (XPON) financials

Income statement

Expion360 Inc. (XPON) income statement, annual, from SEC filings
Fiscal yearFY2021FY2022FY2023FY2024FY2025
Revenue$4.52M$7.16M$5.98M$5.62M$9.65M
Revenue growth—58.6%-16.5%-6.0%71.6%
Gross profit$1.65M$2.29M$1.58M$1.16M$1.34M
Gross margin36.4%31.9%26.3%20.5%13.9%
Operating income-$1.26M-$5.95M-$7.17M-$6.75M-$10.7M
Operating margin-28.0%-83.1%-119.9%-120.1%-110.9%
Net income-$4.72M-$7.54M-$7.46M-$13.5M-$6.24M
Net margin-104.5%-105.2%-124.7%-239.6%-64.6%
EPS (diluted)——-$108.25-$21.03-$1.13

Cash flow

Expion360 Inc. (XPON) cash flow, annual, from SEC filings
Fiscal yearFY2021FY2022FY2023FY2024FY2025
Operating cash flow-$3.90M-$5.47M-$5.53M-$9.56M-$6.15M
Capital expenditures$114K$567K$20.2K——
Free cash flow-$4.01M-$6.04M-$5.55M——

Balance sheet

Expion360 Inc. (XPON) balance sheet, annual, from SEC filings
Fiscal yearFY2021FY2022FY2023FY2024FY2025
Cash & equivalents$773K$7.20M$3.93M$548K$2.97M
Total assets$6.53M$16.7M$11.9M$9.11M$8.07M
Total liabilities$4.27M$5.09M$6.56M$6.59M$1.54M
Long-term debt$779K$439K$298K$198K$166K
Shareholders' equity$2.26M$11.6M$5.35M$2.52M$6.54M
Retained earnings-$6.10M-$13.6M-$21.1M-$34.6M-$40.8M
Shares (wtd avg diluted)4.30M6.80M68.9B641K5.51M

Every figure is extracted from Expion360 Inc.’s annual reports as filed with the SEC (XBRL company facts) — no third-party estimates. Fiscal years are labeled by period end; filers occasionally re-tag concepts, so a sparse cell means the company didn’t report that concept for that year. Free cash flow = operating cash flow − capital expenditures.

Common questions

What is Expion360 Inc.'s annual revenue?
Expion360 Inc. (XPON) reported $9.65M of revenue for fiscal year 2025 — up 71.6% from $5.62M in FY2024, per its annual report filed with the SEC.
Is Expion360 Inc. profitable?
Not in FY2025 — XPON reported a net loss of $6.24M, per SEC filings.
Does XPON pay a dividend?
Expion360 Inc. reported no cash dividends paid in FY2025, per its SEC cash-flow statement.
Full XPON analysis — verdict, score & filings →Is XPON a buy? →

Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.